Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02356354
Other study ID # RB 14.190 NERVAL
Secondary ID
Status Terminated
Phase N/A
First received January 26, 2015
Last updated September 7, 2016
Start date August 2015
Est. completion date September 2016

Study information

Verified date September 2016
Source University Hospital, Brest
Contact n/a
Is FDA regulated No
Health authority France: Agence Nationale de Sécurité du Médicament et des produits de santé
Study type Interventional

Clinical Trial Summary

The aim of this study is to understand why the regeneration of the cutaneous sensory nerve fibers is poor in post-burn scar.

The presence or the lack of several molecular factors known to regulate neuronal cell development will be evaluate and compared within biopsies from healthy skin and post-burn scar.


Recruitment information / eligibility

Status Terminated
Enrollment 6
Est. completion date September 2016
Est. primary completion date August 2016
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Major patients

- At least one year back deep burn (2nd and 3rd degrees), and allowing the comparison between the post-burn scar dermatome and the healthy opposite dermatome

- Patients always followed in the service of Plastic surgery of the hospital of Brest

- Informed consent and paper of the patient after information of the objective of the study and the protocol

- Analog Visual scales for pain and/or pruritus (EVA): greater than or equal to 3

- Simple Verbal scales for the pain and/or the pruritus ( EVS): pain / pruritus moderated to intense

- Membership to the Social Security

Exclusion Criteria:

- Allergy to xylocaine

- Non-Caucasian patients

- Treatments having an effect on the pain and/or the pruritus

- Sun or UV exposure several days preceding or following the biopsies

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label


Related Conditions & MeSH terms


Intervention

Procedure:
Skin biopsy
2 biopsies are done on the same patient : 20 cutaneous biopsies from post-burn scar and from healthy skin

Locations

Country Name City State
France CHRU de Brest Brest

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Brest

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of the differences of expression of genes coding for regulating proteins of the innervation To evaluate the differences of expression of genes coding for regulating proteins of the innervation on samples of healthy skins and post-burn scar. These biopsies will be removed from post-burn patients (at least one year after burn) and allowing the comparison between conflicting dermatomes: a healthy dermatome and a formerly burned dermatome 6 months No
Secondary Validation of the difference of density of intra-epidermic nerve fibers To validate the existence of a difference of density of intra-epidermal nerve fibers between the healthy skins and the post-burn scar. 6 months No